Drug Pipeline

ARV-471 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05654623 A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in… Advanced Breast Cancer Active, Not Recruiting
Phase 2
NCT01042379 I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Breast Neoplasms Recruiting
Phase 1/2
NCT05548127 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With… Breast Cancer Active, Not Recruiting
NCT05573555 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With… Breast Cancer Active, Not Recruiting
Sponsors Running ARV-471 Trials
Disease Areas
Get alerts when ARV-471 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free